Glaxosmithkline Consumer Healthcare is currently trading at Rs. 4305.00, up by 26.00 points or 0.61 % from its previous closing of Rs. 4279.00 on the BSE.
The scrip opened at Rs. 4305.00 and has touched a high and low of Rs. 4319.00 and Rs. 4301.05 respectively. So far 80 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6020.00 on 31-May-2013 and a 52 week low of Rs. 2900.00 on 09-Oct-2012.
Last one week high and low of the scrip stood at Rs. 4433.90 and Rs. 4250.00 respectively. The current market cap of the company is Rs. 18119.21 crore.
The promoters holding in the company stood at 72.46% while Institutions and Non-Institutions held 12.35% and 15.20% respectively.
GlaxoSmithKline Pharmaceuticals’ (GSK Pharma) sales continue to be affected in the major pockets of the country as its products are not being purchased by stockists and retailers from September 15, 2013.
No reason was immediately attributed for this trend but earlier in August the company had said a number of its products have come under the Drug Price Control Order (DPCO) 2013 which has come into effect in May 2013, resulting in reduction of prices of the company’s drugs.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
Company Name | CMP |
---|---|
Nestle | 2510.10 |
Britannia Inds | 4800.40 |
Varun Beverages | 1489.10 |
Marico | 516.75 |
Hatsun Agro Product | 1091.00 |
View more.. |